trial · primary record
Blinatumomab
B Precursor Acute Lymphoblastic Leukemia
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2027-10-14 |
| Primary endpoint | Number of Participants with Complete Remission (CR) |
| Registry ID | NCT06054113 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:54.817Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06054113
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Blinatumomab · approval
- Blinatumomab · compound